Abstract

In the PREVENT trial, 143 adult patients with aquaporin-4 (AQP4) immunoglobin G (IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD) were

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call